
Christopher Morse, MD
Gynecological Oncology in Pittsburgh, PA
- Enrolled in Medicare
- Accepts Medicare assignment
- 14 years since graduation
- Public record — not managed by the clinician
About Dr. Christopher Morse
Dr. Christopher Morse is a physician specializing in gynecological oncology practicing in Pittsburgh, PA, a graduate of Perelman School of Med at the University of Pennsylvania (2012). Affiliated with Canonsburg General Hospital, Jefferson Hospital, West Penn Hospital. Treated 125 Medicare patients in 2024.
- Gynecological Oncology
- Division of Hematology and Cellular Therapy
- Accepts Medicare assignment
- In-person visits at the practice
Provider details
| Specialty | Gynecological OncologyOther gynecological oncology doctors in Pittsburgh |
|---|---|
| Credentials | MD |
| Education | Perelman School of Med at the University of Pennsylvania, 2012CMS Doctors and Clinicians |
| Gender | Male |
| NPI number | 1689940017National Provider Identifier (CMS NPPES), issued March 2012 |
| Medicare | Enrolled in Medicare; accepts Medicare assignment (the Medicare-approved amount as full payment)CMS Doctors and Clinicians |
Dr. Christopher Morse's specialties and state licenses
- Gynecologic Oncology Primary
License: PA MD471044 - Obstetrics & Gynecology
License: WA ML60289093
As reported by the clinician to the NPPES registry. Confirm a license and any disciplinary history with the state medical or licensing board.
Where Dr. Christopher Morse practices
-
Division of Hematology and Cellular Therapy 4815 Liberty Ave, Suite 250, Pittsburgh, PA 15224 (412) 578-1116 Group of 2,439 clinicians Directions Call office View clinic details
Addresses from CMS Doctors and Clinicians (Medicare enrollment). Call before visiting: a clinician may not see patients at every listed address.
Hospital affiliations of Dr. Christopher Morse
- Canonsburg General HospitalHospital · Canonsburg, PA
- Jefferson HospitalHospital · Jefferson Hills, PA
- West Penn HospitalHospital · Pittsburgh, PA
CMS Facility Affiliation data: facilities where the clinician bills Medicare.
Dr. Christopher Morse's Medicare quality score (MIPS 2024)
The Merit-based Incentive Payment System scores clinicians who bill Medicare. Reported as apm. Source: CMS Care Compare, PY 2024 clinician public reporting.
Dr. Christopher Morse's Medicare patients and services (2024)
Most frequent services
| Service | Times | Avg. Medicare allowed |
|---|---|---|
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 92 | $88.13 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 80 | $123.51 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 37 | $48.06 |
| New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more | 36 | $215.08 |
| Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | 13 | $893.15 |
Common conditions among these patients
Medicare Part B fee-for-service claims only (CMS Medicare Physician & Other Practitioners, 2024). Patients with private insurance or Medicare Advantage are not counted; small counts are suppressed by CMS. This describes the patients, not the quality of care.
Payments from drug and device companies to Dr. Christopher Morse (2025)
$212.21 in 3 general payments reported in 2025.
| Type | Payments | Amount |
|---|---|---|
| Food and beverage | 3 | $212.21 |
Paying companies: AstraZeneca Pharmaceuticals LP ($212.21).
Reported by companies under the federal Open Payments program (CMS, program year 2025). A payment, such as a meal at an educational event, does not mean wrongdoing; clinicians can dispute records with CMS.
Also at Division of Hematology and Cellular Therapy
- Beth Prairie, MDObstetrics & Gynecology Division of Hematology and Cellular Therapy
- Brett Hartman, DOPlastic & Reconstructive Surgery Division of Hematology and Cellular Therapy
- Karl R. Saltrick, DPMPodiatry Division of Hematology and Cellular Therapy
- Christine K. Rauscher, MDAllergy/immunology Division of Hematology and Cellular Therapy
- John Nakayama, MDGynecological Oncology Division of Hematology and Cellular Therapy
- Howard Edington, MDPlastic & Reconstructive Surgery Division of Hematology and Cellular Therapy
Questions about Dr. Christopher Morse
What kind of clinician is Dr. Christopher Morse?
Dr. Christopher Morse is listed as a physician specializing in gynecological oncology.
Where does Dr. Christopher Morse practice?
Division of Hematology and Cellular Therapy at 4815 Liberty Ave, Suite 250, Pittsburgh, PA 15224.
What is the office phone number for Dr. Christopher Morse?
The listed office number is (412) 578-1116. Call to confirm availability and whether new patients are accepted.
What is the NPI number of Dr. Christopher Morse?
The National Provider Identifier is 1689940017.
Does Dr. Christopher Morse accept Medicare?
Yes. CMS lists this clinician as accepting Medicare assignment. Confirm your plan with the office.
Which hospitals is Dr. Christopher Morse affiliated with?
Canonsburg General Hospital, Jefferson Hospital, West Penn Hospital.
Where did Dr. Christopher Morse go to medical school?
Perelman School of Med at the University of Pennsylvania, graduating in 2012.
Where this information comes from
| CMS Doctors and Clinicians | Name, specialty, education, Medicare enrollment and practice addresses.Centers for Medicare & Medicaid Services, national downloadable file (2026) |
|---|---|
| NPPES NPI registry | NPI, specialties (taxonomy) and state licenses.CMS National Plan and Provider Enumeration System; record updated 2021-08-12 |
| Facility affiliations | Hospitals and other facilities.CMS Doctors and Clinicians facility affiliation file; names from CMS Provider of Services |
| Medicare utilization | Patients, services and conditions.CMS Medicare Physician & Other Practitioners, 2024 |
| MIPS | Quality payment program scores.CMS clinician public reporting, PY 2024 |
| Open Payments | Payments from drug and device companies.CMS Open Payments, program year 2025 |
Information is public record and may lag behind changes. Clinicians update it through NPPES and Medicare PECOS. See something wrong? Tell us.
Need an appointment?
Call Division of Hematology and Cellular Therapy at (412) 578-1116 or visit the clinic page to check availability.